Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets

Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets

Clear cell renal cell carcinoma (ccRCC) is the most frequent histological kidney cancer subtype. Over the last decade, significant progress has been made in identifying the genetic and metabolic alterations driving ccRCC development. In particular, an integrated approach using transcriptomics, metab...

Full description

Bibliographic Details
Main Authors: Nicola Antonio di Meo, Francesco Lasorsa, Monica Rutigliano, Davide Loizzo, Matteo Ferro, Alessandro Stella, Cinzia Bizzoca, Leonardo Vincenti, Savio Domenico Pandolfo, Riccardo Autorino, Felice Crocetto, Emanuele Montanari, Marco Spilotros, Michele Battaglia, Pasquale Ditonno, Giuseppe Lucarelli
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:International Journal of Molecular Sciences
Subjects:
renal cell carcinoma
metabolomics
metabolism
Warburg effect
biomarker
Online Access:https://www.mdpi.com/1422-0067/23/22/14360

Internet

https://www.mdpi.com/1422-0067/23/22/14360

Similar Items